Pages that link to "Q42400885"

The following pages link to Rapamycin as longevity enhancer and cancer preventative agent in the context of p53 deficiency (Q42400885):

Displaying 24 items.

• Latest progress in tyrosine kinase inhibitors (Q33576849) (← links)
• From rapalogs to anti-aging formula (Q33829205) (← links)
• AZD1480 delays tumor growth in a melanoma model while enhancing the suppressive activity of myeloid-derived suppressor cells. (Q34334399) (← links)
• TOR-centric view on insulin resistance and diabetic complications: perspective for endocrinologists and gerontologists (Q34391710) (← links)
• Selective anti-cancer agents as anti-aging drugs (Q34392470) (← links)
• Catalytic mTOR inhibitors can overcome intrinsic and acquired resistance to allosteric mTOR inhibitors (Q34483665) (← links)
• Gerosuppression in confluent cells (Q34982499) (← links)
• Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion (Q35149607) (← links)
• Geroconversion: irreversible step to cellular senescence (Q36186369) (← links)
• Comparison of rapamycin schedules in mice on high-fat diet (Q36189078) (← links)
• Rejuvenating immunity: "anti-aging drug today" eight years later (Q36260537) (← links)
• Koschei the immortal and anti-aging drugs (Q36292001) (← links)
• The combinatorial activation of the PI3K and Ras/MAPK pathways is sufficient for aggressive tumor formation, while individual pathway activation supports cell persistence (Q36546319) (← links)
• Rapamycin reverses the senescent phenotype and improves immunoregulation of mesenchymal stem cells from MRL/lpr mice and systemic lupus erythematosus patients through inhibition of the mTOR signaling pathway (Q37062514) (← links)
• MTOR-driven quasi-programmed aging as a disposable soma theory: blind watchmaker vs. intelligent designer (Q37075896) (← links)
• CDK4/6-inhibiting drug substitutes for p21 and p16 in senescence: duration of cell cycle arrest and MTOR activity determine geroconversion (Q37420058) (← links)
• S6K in geroconversion (Q37452951) (← links)
• Dysregulation of the mTOR pathway in p53-deficient mice (Q37548879) (← links)
• mTOR pathway in colorectal cancer: an update (Q37649634) (← links)
• Reduced bioenergetics and toll-like receptor 1 function in human polymorphonuclear leukocytes in aging (Q37671520) (← links)
• p53, a translational regulator: contribution to its tumour-suppressor activity. (Q38366523) (← links)
• Molecular dynamics of the full-length p53 monomer (Q42103308) (← links)
• Immunosuppressants in cancer prevention and therapy (Q42505783) (← links)
• While reinforcing cell cycle arrest, rapamycin and Torins suppress senescence in UVA-irradiated fibroblasts (Q49713212) (← links)